BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 4285450)

  • 1. Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection.
    Gold E
    N Engl J Med; 1966 Jan; 274(4):181-5. PubMed ID: 4285450
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous interferon production in patients with Hodgkin's disease and other cancers infected with varicella or vaccinia.
    Armstrong RW; Gurwith MJ; Waddell D; Merigan TC
    N Engl J Med; 1970 Nov; 283(22):1182-7. PubMed ID: 4319626
    [No Abstract]   [Full Text] [Related]  

  • 3. Radioimmunoassay for antibodies in varicella-zoster virus serology.
    Trlifajova J; Pokorný J; Nĕmecek V; Ryba M
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):332-9. PubMed ID: 231068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect haemagglutination reaction with varicella-zoster virus antigen.
    Trlifajová J; Pokorný J; Ryba M; Strízová V
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):26-36. PubMed ID: 4350836
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigenic relationship between varicella-herpes zoster and herpes simplex viruses studied by the gel precipitation reaction.
    Trlifajová J; Sourek J; Ryba M
    Acta Virol; 1971 Jul; 15(4):293-300. PubMed ID: 4398080
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of the Tzanck smear and viral isolation in varicella and herpes zoster.
    Solomon AR; Rasmussen JE; Weiss JS
    Arch Dermatol; 1986 Mar; 122(3):282-5. PubMed ID: 3006599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoster immune globulin. A further assessment.
    Gershon AA; Steinberg S; Brunell PA
    N Engl J Med; 1974 Jan; 290(5):243-5. PubMed ID: 4358055
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster.
    Asano Y; Takahashi M
    Biken J; 1978 Mar; 21(1):15-23. PubMed ID: 208504
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell-mediated immunity to varicella-zoster virus as assessed by the migration inhibition test.
    Trlifajová J; Svejcar J; Svandová E; Ryba M; Pekárek J
    Acta Virol; 1980 Dec; 24(6):406-14. PubMed ID: 6111201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella-Zoster infection in patients with cancer.
    Schimpff S; Serpick A; Stoler B; Rumack B; Mellin H; Joseph JM; Block J
    Ann Intern Med; 1972 Feb; 76(2):241-54. PubMed ID: 4333228
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of concentrated intracellular precipitating antigens of varicella-zoster and herpes simplex viruses and results obtained with them in the gel precipitation reaction.
    Trlifajová J; Sourek J; Ryba M
    Acta Virol; 1970 Jan; 14(1):25-34. PubMed ID: 4392074
    [No Abstract]   [Full Text] [Related]  

  • 13. Humoral and cellular immunity to varicella-zoster virus: an overview.
    Arvin AM
    J Infect Dis; 2008 Mar; 197 Suppl 2():S58-60. PubMed ID: 18419410
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
    Wood SM; Shah SS; Steenhoff AP; Rutstein RM
    Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
    Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
    Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.
    Schmidt NJ; Lennette EH; Magoffin RL
    J Gen Virol; 1969 Apr; 4(3):321-8. PubMed ID: 4306713
    [No Abstract]   [Full Text] [Related]  

  • 17. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella and herpes zoster: differences in antibody response revealed by the platelet aggregation technique.
    Palosuo T
    Scand J Infect Dis; 1972; 4(2):83-9. PubMed ID: 4341817
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and pathogenetic aspects of varicella-zoster.
    Plotkin SA
    Postgrad Med J; 1985; 61 Suppl 4():7-14. PubMed ID: 3014481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella-zoster vaccine for the prevention of herpes zoster.
    Kimberlin DW; Whitley RJ
    N Engl J Med; 2007 Mar; 356(13):1338-43. PubMed ID: 17392303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.